癌变·畸变·突变 ›› 1999, Vol. 11 ›› Issue (5): 252-256.doi: 10.3969/j.issn.1004-616x.1999.05.017

• 交流论文 • 上一篇    下一篇

用多终点体内试验法研究硫丹的雌激素活性

裘炯良  常 艳 朱心强   

  1. 浙江大学湖滨校区毒理学研究室 杭州 310006
  • 收稿日期:1999-03-29 修回日期:1999-08-15 出版日期:1999-09-30 发布日期:1999-09-30

USE IN VIVO MULTIPLE ENDPOINTS ASSAY FOR STUDYING ESTROUSE IN VIVO MULTIPLE ENDPOINTS ASSAY FOR STUDYING ESTRO2

Qiu J iongliang , Chang Yan , Zhu Xinqiang   

  1. Department of Toxicology , Zhejiang University , Hangz hou  310006
  • Received:1999-03-29 Revised:1999-08-15 Online:1999-09-30 Published:1999-09-30

摘要: 为研究硫丹是否具有雌激素活性,以摘除卵巢的NIH 雌性小鼠为对象,用多终点体内试验法,观察子宫体重比、子宫积液、动情周期转换、子宫上皮细胞高度及子宫基质细胞层厚度五项指标。结果显示:硫丹组(0. 5mg/ kg/ d ,1. 5mg/ kg/ d 和3.0mg/ kg/ d) 的五项指标值与阴性对照组相比无显著性差异,且三个组之间无明显的剂量—反应关系。以上结果提示在本实验条件下,硫丹不具有雌激素活性。

关键词: 硫丹, 雌激素活性, 多终点测定

Abstract: We combined five endpoint s into a single 52day in vivo screening assay to identify est rogenicity of enosulfan. The endpoint s evaluated as markers of esrogenicity included the ratio of uterine weight/ body weight , uterine fluid imbibition , vaginal cornification incidence , uterine st roma cell proliferation and uterine epithelial cell height . The endosulfan were administered daily p. o. for 5 days to sexually mature ovariectomized female NIH mice. Compared with the five endpoint s of the three dosage groups of edosulfan (0. 5mg/ kg/ d ,1. 5mg/ kg/d and 3. 0 mg/ kg/ d) showed no significant difference and no significant dose2response. Thus , endosulfan has no est rogenicity under the experimental condition.

Key words: Endosulfan, Est rogenicity, Multiple endpoint s